Sihuan Pharmaceutical Holdings Group Ltd. (0460.HK)
HKD 0.64
(1.59%)
HKD 0.64
(1.59%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 1.29 Billion CNY | -12.9% |
| 2022 | 1.48 Billion CNY | -38.79% |
| 2021 | 2.43 Billion CNY | 26.95% |
| 2020 | 1.91 Billion CNY | -16.38% |
| 2019 | 2.28 Billion CNY | -3.77% |
| 2018 | 2.37 Billion CNY | 19.74% |
| 2017 | 1.98 Billion CNY | -9.23% |
| 2016 | 2.18 Billion CNY | -1.76% |
| 2015 | 2.22 Billion CNY | 5.52% |
| 2014 | 2.11 Billion CNY | -42.93% |
| 2013 | 3.69 Billion CNY | 61.6% |
| 2012 | 2.28 Billion CNY | 33.54% |
| 2011 | 1.71 Billion CNY | 130.21% |
| 2010 | 744.74 Million CNY | 44.05% |
| 2009 | 516.99 Million CNY | 37.32% |
| 2008 | 376.49 Million CNY | 66.72% |
| 2007 | 225.82 Million CNY | 80.84% |
| 2006 | 124.87 Million CNY | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | 608.51 Million CNY | 0.0% |
| 2023 FY | 1.29 Billion CNY | -12.9% |
| 2023 Q2 | 747.73 Million CNY | 0.0% |
| 2023 Q4 | 547.91 Million CNY | 0.0% |
| 2022 FY | 1.48 Billion CNY | -38.79% |
| 2022 Q2 | 1 Billion CNY | 0.0% |
| 2021 FY | 2.43 Billion CNY | 26.95% |
| 2021 Q2 | 1.46 Billion CNY | 0.0% |
| 2020 Q2 | 786.05 Million CNY | 0.0% |
| 2020 Q4 | 1.12 Billion CNY | 0.0% |
| 2020 FY | 1.91 Billion CNY | -16.38% |
| 2019 Q4 | 923.78 Million CNY | 0.0% |
| 2019 Q2 | 1.36 Billion CNY | 0.0% |
| 2019 FY | 2.28 Billion CNY | -3.77% |
| 2018 FY | 2.37 Billion CNY | 19.74% |
| 2018 Q4 | 1.35 Billion CNY | 0.0% |
| 2018 Q2 | 1.02 Billion CNY | 0.0% |
| 2017 Q2 | 1.01 Billion CNY | 0.0% |
| 2017 Q4 | 968.48 Million CNY | 0.0% |
| 2017 FY | 1.98 Billion CNY | -9.23% |
| 2016 Q2 | 927.42 Million CNY | 0.0% |
| 2016 FY | 2.18 Billion CNY | -1.76% |
| 2016 Q4 | 1.26 Billion CNY | 0.0% |
| 2015 Q4 | 949.2 Million CNY | 0.0% |
| 2015 FY | 2.22 Billion CNY | 5.52% |
| 2015 Q2 | 1.27 Billion CNY | 0.0% |
| 2014 FY | 2.11 Billion CNY | -42.93% |
| 2014 Q4 | 1.15 Billion CNY | 0.0% |
| 2014 Q2 | 960.55 Million CNY | 0.0% |
| 2013 FY | 3.69 Billion CNY | 61.6% |
| 2013 Q4 | -391.64 Million CNY | -142.34% |
| 2013 Q3 | 924.92 Million CNY | -49.93% |
| 2013 Q2 | 1.84 Billion CNY | 99.7% |
| 2013 Q1 | 924.92 Million CNY | 0.0% |
| 2012 Q4 | 924.92 Million CNY | 61.6% |
| 2012 FY | 2.28 Billion CNY | 33.54% |
| 2012 Q2 | 572.35 Million CNY | 0.0% |
| 2012 Q1 | 572.35 Million CNY | 0.0% |
| 2012 Q3 | 572.35 Million CNY | 0.0% |
| 2011 Q4 | 572.35 Million CNY | 33.54% |
| 2011 Q3 | 428.61 Million CNY | 0.0% |
| 2011 Q2 | 428.61 Million CNY | 0.0% |
| 2011 Q1 | 428.61 Million CNY | 0.0% |
| 2011 FY | 1.71 Billion CNY | 130.21% |
| 2010 Q4 | 428.61 Million CNY | 130.21% |
| 2010 FY | 744.74 Million CNY | 44.05% |
| 2010 Q1 | 186.18 Million CNY | 0.0% |
| 2010 Q2 | 186.18 Million CNY | 0.0% |
| 2010 Q3 | 186.18 Million CNY | 0.0% |
| 2009 Q4 | 186.18 Million CNY | 44.05% |
| 2009 FY | 516.99 Million CNY | 37.32% |
| 2009 Q3 | 129.24 Million CNY | 0.0% |
| 2009 Q2 | 129.24 Million CNY | 0.0% |
| 2009 Q1 | 129.24 Million CNY | 0.0% |
| 2008 Q3 | 94.12 Million CNY | 0.0% |
| 2008 Q1 | 94.12 Million CNY | 0.0% |
| 2008 FY | 376.49 Million CNY | 66.72% |
| 2008 Q2 | 94.12 Million CNY | 0.0% |
| 2008 Q4 | 129.24 Million CNY | 37.32% |
| 2007 Q2 | 56.45 Million CNY | 0.0% |
| 2007 Q1 | 56.45 Million CNY | 0.0% |
| 2007 Q3 | 56.45 Million CNY | 0.0% |
| 2007 FY | 225.82 Million CNY | 80.84% |
| 2007 Q4 | 94.12 Million CNY | 66.72% |
| 2006 FY | 124.87 Million CNY | 0.0% |
| 2006 Q1 | 31.21 Million CNY | 0.0% |
| 2006 Q3 | 31.21 Million CNY | 0.0% |
| 2006 Q4 | 56.45 Million CNY | 80.84% |
| 2006 Q2 | 31.21 Million CNY | 0.0% |
| 2005 Q4 | 31.21 Million CNY | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Pak Fah Yeow International Limited | 167.43 Million HKD | -673.814% |
| Grand Pharmaceutical Group Limited | 6.52 Billion HKD | 80.141% |
| Extrawell Pharmaceutical Holdings Limited | 28.77 Million HKD | -4402.047% |
| Wai Yuen Tong Medicine Holdings Limited | 394.81 Million HKD | -228.166% |
| Qianhai Health Holdings Limited | -35.6 Million HKD | 3739.143% |
| Lee's Pharmaceutical Holdings Limited | 551.31 Million HKD | -135.011% |
| Essex Bio-Technology Limited | 1.53 Billion HKD | 15.829% |
| Tongfang Kontafarma Holdings Limited | 471.29 Million HKD | -174.913% |
| PuraPharm Corporation Limited | 216.62 Million HKD | -498.094% |
| SSY Group Limited | 3.48 Billion HKD | 62.867% |
| JBM (Healthcare) Limited | 319.41 Million HKD | -305.629% |
| Jacobson Pharma Corporation Limited | 620.47 Million HKD | -108.815% |
| China Resources Pharmaceutical Group Limited | 43.36 Billion HKD | 97.012% |